FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Mary Lou Chatterton

Research Profile

Disorders

Activities & Behaviors

Concepts & Ideas

Living Beings

Human Respiratory Syncytial Virus

Chemicals & Drugs

Geographic Areas

Physiology

Emotions

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Mary Lou Chatterton; Jennifer H Lofland; Aaron Shechter; Walter Scott Curtice; X Henry Hu; Jeffrey Lenow; Stanton N Smullens; David B Nash; Stephen D Silberstein
Reliability and validity of the migraine therapy assessment questionnaire.
Jennifer H Lofland; S S Kim; Alice S Batenhorst; N E Johnson; Mary Lou Chatterton; Roger K Cady; R Kaniecki; David B Nash
Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Jennifer H Lofland; John P O'Connor; Mary Lou Chatterton; Elizabeth D Moxey; LE Paddock; David B Nash; SA Desai
Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Mary Lou Chatterton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: Mary Lou Chatterton; Jennifer H Lofland; Aaron Shechter; Walter Scott Curtice; X Henry Hu; Jeffrey Lenow; Stanton N Smullens; David B Nash; Stephen D Silberstein
Reliability and validity of the migraine therapy assessment questionnaire.
Headache 2002;42(10):1006-15.
2001: Jennifer H Lofland; S S Kim; Alice S Batenhorst; N E Johnson; Mary Lou Chatterton; Roger K Cady; R Kaniecki; David B Nash
Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Mayo Clinic proceedings. Mayo Clinic 2001;76(11):1093-101.
2000: Jennifer H Lofland; John P O'Connor; Mary Lou Chatterton; Elizabeth D Moxey; LE Paddock; David B Nash; SA Desai
Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis.
Clinical therapeutics 2000;22(11):1357-69.
2000: LE Paddock; J Veloski; Mary Lou Chatterton; F O Gevirtz; David B Nash
Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management.
Diabetes care 2000;23(7):951-6.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.